References
- Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997;337:663–9
- Kalodiki E, Nikolaides AN. Superficial thrombophlebitis and low-molecular-weight heparins. Angiology 2002;53:659–63
- Levine M, Raskob G, Landefeld K, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001;119(Suppl):108S–121S
- Lapidus L, Borretzen J, Fahlen M, Thomsen HG, Hasselblom S, Larson L, et al. Home treatment of deep vein thrombosis. An outpatient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients. Pathophysiol Haemost Thromb 2002;32:59–66
- Montoya JP, Pokala N, Melde SL. Retroperitoneal hematoma and enoxaparin. [Letter]. Ann Intern Med 1999;131:796–7
- Albada J, Nieuwenhuis HK, Sixma JJ. Treatment of acute venous thromboembolism with low-molecular-weight heparin (Fragmin): results of a double-blind randomized study. Circulation 1989;80:935–40